Page 59 - CIBEROBN2016-ENG

Most relevant scientific articles
• Bray G.A., Fruhbeck G., Ryan D.H., Wilding J.P.H. Management of obesity. The Lancet. 2016;387(10031):1947-1956.
• Moncada R., Landecho M.F., Fruhbeck G. Metabolic Surgery Enters the T2DM Treatment Algorithm. Trends in Endocrinology and Metabolism. 2016;27(10):678-680.
• Gómez-Ambrosi J., Pascual-Corrales E., Catalán V., Rodríguez A., Ramírez B., Romero S. et al. Altered concentrations in dyslipidemia evidence a role for ANGPTL8/betatrophin in lipid metabolism in humans. Journal of Clinical Endocrinology and Metabolism. 2016;101(10):3803-3811.
• Catalán V., Gómez-Ambrosi J., Rodríguez A., Ramírez B., Valentí V., Moncada R. et al. Increased interleukin-32 levels in obesity promote adipose tissue inflammation and extracellular matrix remodeling: Effect of weight loss. Diabetes. 2016;65(12):3636-3648.
• Ezquerro S., Méndez-Giménez L., Becerril S., Moncada R., Valentí V., Catalán V. et al. Acylated and desacyl ghrelin are associated with hepatic lipogenesis, β-oxidation and autophagy: Role in NAFLD amelioration after sleeve gastrectomy in obese rats. Scientific Reports. 2016;6.
Hightlights
RESEARCH PROJECTS:
• Prospective study of the changes in energy expenditure after bariatric surgery. FIS_INTRASALUD-ISCIII_
Frühbeck.
• Identification of novel modulators of chronic inflammation in prevalent diseases: unveiling divergent
mechanisms of disease (INFLAMES). FIS-ISCIII.
• Study of the implication of osteopontin in colon cancer development in the context of obesity. FIS-
ISCIII_Gómez Ambrosi.
• Study of the regulation of aquagliceroporins in insulin-sensitive tissues in an obesity and insulin
resistance context. Dept. Salud, GobNav_Rodríguez.
• Implication of ghrelin isoforms in the development of steatosis and non-alcoholic steatohepatitis
associated with obesity and insulin resistance. FIS-ISCIII_Rodríguez.
• Identification of novel modulators of chronic inflammation in prevalent diseases: unveiling divergent
mechanisms of disease. FIS-ISCIII.
• Role of interleukin-32 in the regulation of macrophage polarization in adipose tissue. Involvement in
the obesity-associated inflammation and comorbidities. FIS-ISCIII_Catalán.
CLINICAL GUIDELINES:
• EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016 Jun;64(6):1388-402.
• EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease. Obes Facts. 2016;9(2):65-90.
• EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Diabetologia. 2016 Jun;59(6):1121-40.
• 2015 Milan Declaration: A Call to Action on Obesity - an EASO Position Statement on the Occasion of the 2015 EXPO. Obes Facts. 2016;9(4):296-8.
• Prevención, diagnóstico y tratamiento de la obesidad. Posicionamiento de la Sociedad Española para el Estudio de la Obesidad de 2016 Endocrinol Nutr. 2016 Aug 16.
• Indicators for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg. 2016 Aug;26(8):1659-96. https://www.ncbi.nlm.nih.gov/pubmed/27412673
Research groups 59
• Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Diabetes Care. 2016 Jun;39(6):861-77.
OBN